Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,759,158,041
+$782,522,646 QoQ
Shares Held
11,471,413
-5.0% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#14
of 4,587 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. LLY ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,759,158,041 | 11,471,413 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $12,976,635,395 | 12,074,882 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $8,827,714,209 | 11,324,406 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,081,166,214 | 10,995,346 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $8,407,907,584 | 10,891,072 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $9,290,878,472 | 10,487,029 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $9,963,572,903 | 11,004,852 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,336,634,141 | 10,716,019 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $5,992,889,765 | 10,280,810 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,301,569,246 | 9,870,179 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $4,618,375,283 | 9,847,702 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $3,313,628,328 | 9,648,909 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $3,416,205,871 | 9,337,978 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,769,611,096 | 8,565,366 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $2,690,047,470 | 8,296,726 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $2,323,917,750 | 8,115,088 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $2,213,765,190 | 8,014,500 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $1,908,633,810 | 8,260,696 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $1,954,399,752 | 8,515,161 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $1,641,546,239 | 8,786,780 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $1,463,292,888 | 8,666,743 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $1,278,567,600 | 8,637,803 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $1,372,090,842 | 8,357,235 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $1,222,309,500 | 8,811,343 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||